Clinical outcomes and safety of anakinra in the treatment of multisystem inflammatory syndrome in children: a single center observational study

BACKGROUND AND OBJECTIVE: Evidence for the treatment of multisystem inflammatory syndrome in children (MIS-C) is lacking. Anakinra, which targets IL-1-mediated inflammation, is reserved for refractory cases of MIS-C; however, its use in the treatment of MIS-C is not clearly established. PATIENTS AND...

Descripción completa

Detalles Bibliográficos
Autores principales: Dizon, Brian L.P., Redmond, Christopher, Gotschlich, Emily C., Sule, Sangeeta, Ronis, Tova, Vazzana, Kathleen M., Sherman, Matthew A., Connor, Rachael, Bosk, Abigail, Dham, Niti, Harahsheh, Ashraf S., Wells, Elizabeth, DeBiasi, Roberta, Srinivasalu, Hemalatha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388456/
https://www.ncbi.nlm.nih.gov/pubmed/37525200
http://dx.doi.org/10.1186/s12969-023-00858-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388456/
https://www.ncbi.nlm.nih.gov/pubmed/37525200
http://dx.doi.org/10.1186/s12969-023-00858-z

Ejemplares similares